JPRN-UMIN000029320招募中未知
Immune function analysis after sirolimus treatment for pediatric patients with intractable vascular anomalies - Immune function analysis after sirolimus treatment for pediatric patients with intractable vascular anomalies
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with a history of hypersensitivity to ingredients of this drug 2. Patients with serious liver and renal disorders 3. Patients with symptoms that affect cytokine value of such obvious infection at the time of specimen collection 4. Patients must also avoid strong inducers of CYP3A4 5. Past usage of mTOR inhibitors or other molecular target drugs relating mTOR pathway 6. Patient who is judged inappropriate to participate in this study by the investigators
研究者
相似试验
已完成
不适用
Clinical study on efficacy and safety of sirolimus against epileptic seizures of focal cortical dysplasia type IIPatients with epilepsy with focal cortical dysplasia type 2JPRN-UMIN000030962Hokkaido University Hospital2
已完成
2 期
An open label phase II study of Sirolimus in patients with segmental overgrowth syndromeSEGMENTAL OVERGROWTH SYNDROMEQ85.8Q87.8Q87.3Other phakomatoses, not elsewhere classifiedOther specified congenital malformation syndromes, not elsewhere classifiedCongenital malformation syndromes involving early overgrowthDRKS00010085niversitätsklinikum Freiburg18
进行中（未招募）
1 期
Studie zu Sirolimus bei Patienten mit ÜberwuchssyndromSegmental overgrowth syndromeEUCTR2015-005416-15-DEMedical Center - University of Freiburg18
进行中（未招募）
1 期
Prospective comparison of sirolimus against corticosteroids in treatment of patients with active thyroid eye diseaseThyroid eye diseaseCTIS2023-510166-27-01Helse Bergen HF70
尚未招募
Unknown
Bioequivalence study of Sirolimus 1mg tabletIRCT20200623047902N35Zist takhmir company24